SK bioscience has secured its first UNICEF procurement contract for influenza vaccines under the 2026 immunization programmes.
Approximately 640,000 doses are scheduled for delivery throughout the year.
Read more: https://t.co/wwcanu9sPA
EMBALL'ISO will be exhibiting at CPHI China 2026. With over 35 years of experience in cold chain management, EMBALL'ISO has established itself as a pioneer in sustainable isothermal packaging.
Heading to Shanghai? Stop by and meet the team.
RealCold has acquired SCL Cold Chain, known for its temperature-controlled expertise across specialized sectors including pharmaceuticals and medical devices.
Read more: https://t.co/gixAqBnl69
London Biotechnology Show 2026 is taking place at Excel London this November, aligning with London Life Sciences Week to create one of the UK’s most influential gatherings for the global life sciences and biotech community.
Register: https://t.co/9kdFxxi0f1
AGC Biologics has been selected by Teikoku Seiyaku to provide microbial development and manufacturing services for KTP-001. The partnership highlights AGC Biologics’ global CDMO network, which provides supply chain security... Read more: https://t.co/XzzqF2eH0V
Lufthansa Cargo has received comprehensive IATA CEIV Pharma certification, covering airline processes and IATA’s corporate approach to assessing quality management across part of the network.
Read more: https://t.co/ymRBiG86V6
Hanmi Pharmceutical has signed a supply agreement with Organon to export three combination medicines to Malaysia and the Philippines.
Read more: https://t.co/FMz8DHz2Oo
#HanmiPharmaceutical#Organon#PharmaSupplyChain
Fosun Pharma and AriBio have signed an exclusive global option agreement for AR1001, an Alzheimer’s disease drug candidate. AR1001 is being evaluated in POLARIS-AD, a global Phase 3 trial with more than 1,500 patients enrolled.
https://t.co/TS2pj9vgkb
Successful digitalisation is no longer about running pilots. AUTOMA+ 2026 will take place in Zurich, Switzerland, on 16–17 November, focusing on practical digitalisation for industrial pharma.
Read more: https://t.co/nivb4FmCfg
Samsung Bioepis has launched its ustekinumab biosimilar (SB17) in Japan, in partnership with NIPRO CORPORATION. This marks the company’s first product launch in the Japanese market.
Read more: https://t.co/smrTCC07Si
The biotech community is gearing up for UK Biotech Day 2026. The event brings together innovators, investors, and industry leaders to discuss cutting-edge research, investment opportunities, and the future of biote in Europe.
For more information: https://t.co/MLRy51uHAx
“Innovating for the innovators.”
Peli BioThermal CEO Sam Herbert used this phrase to describe the company’s role in pharma supply chains during his conversation with Linda Kim at LogiPharma in Vienna.
🎬 Watch the full interview here: https://t.co/MYTUasq7PY
LOTTE Biologics has expanded its collaboration with Ottimo Pharma to support OTP-01 toward launch readiness, with commercial process development and characterization activities at its Syracuse Bio Campus.
Read more: https://t.co/ZYawHPEIWc
Envirotainer held Connecting Pharma Supply Chains – Korea 2026 in Incheon, bringing together stakeholders from across the pharmaceutical cold chain ecosystem, including pharmaceutical companies, airlines, and logistics providers.
Read more: https://t.co/zPODxDYJJl
🔍 CCP Directory Spotlight: SkyCell AG
SkyCell’s profile in the CCP directory now highlights its latest developments, including the 6500X multi-pallet, multimodal pharma container and the Validaide Platform.
🔗 Explore SkyCell’s key solutions here: https://t.co/zfxo4jNhNq
Vetter has started construction of a new production site in Saarlouis, Germany, marking a significant expansion of its CDMO manufacturing capacity. Almost half a billion euros is planned for investment by the expected commissioning in 2031.
Read more: https://t.co/R4pb3989RM
Huons BioPharma has secured approval from Kuwait’s Ministry of Health for Hutox, its botulinum toxin product.
With regulatory approvals now secured in 16 countries, Huons BioPharma continues to build its global presence in the botulinum toxin market.
https://t.co/tLLCkF1p1o
Taiwan-based Bora Pharmaceuticals has announced Bora Group’s acquisition of the GMP manufacturing operations and CDMO business of MacroGenics, Inc. for US$122.5 million, further expanding its biologics manufacturing footprint in North America.
Read more: https://t.co/HzgfjUty0V
In this on-site interview at LogiPharma 2026, Joydeep Ganguly of Agilent Technologies joins Linda Kim to discuss Pharma’s 4IR and its impact on operations, supply chain, quality, and people.
📷 Watch the full interview: https://t.co/U6953rqQrC